
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.24 | 2.15 | 0.91 |
Stocks | 98.75 | 98.78 | 0.03 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.65 | 20.45 |
Price to Book | 4.08 | 4.07 |
Price to Sales | 2.23 | 2.45 |
Price to Cash Flow | 15.33 | 16.43 |
Dividend Yield | 1.94 | 1.36 |
5 Years Earnings Growth | 9.40 | 12.13 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.59 | 94.83 |
Basic Materials | 0.33 | 1.32 |
Consumer Defensive | 0.05 | 3.36 |
Financial Services | 0.02 | 8.85 |
Number of long holdings: 185
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.51 | 822.72 | +0.13% | |
UnitedHealth | US91324P1021 | 6.47 | 519.14 | +0.66% | |
J&J | US4781601046 | 4.80 | 164.31 | +0.72% | |
AbbVie | US00287Y1091 | 4.32 | 202.81 | +0.04% | |
Novo Nordisk B | DK0062498333 | 3.68 | 475.1 | -1.15% | |
Merck&Co | US58933Y1055 | 3.47 | 89.62 | +2.31% | |
Roche Holding Participation | CH0012032048 | 2.79 | 294.60 | +0.07% | |
Thermo Fisher Scientific | US8835561023 | 2.75 | 505.48 | -1.21% | |
Novartis | CH0012005267 | 2.71 | 98.22 | -0.07% | |
Abbott Labs | US0028241000 | 2.70 | 131.55 | +0.15% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust C Acc | 3.42B | 4.50 | 15.58 | 15.55 | ||
Legal General US Index Trust C Dist | 798.28M | 4.51 | 15.59 | 15.55 | ||
Legal General US Index Trust I Acc | 1.57B | 27.16 | 11.15 | 15.07 | ||
Legal General US Index Trust I Dist | 1.63B | 27.16 | 11.15 | 15.07 | ||
Legal General US Index Trust F Acc | 527.55K | 4.46 | 15.26 | 15.22 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review